Anteris Technologies Global (AVR) Gains from Investment Securities (2024 - 2025)

Anteris Technologies Global (AVR) reported Gains from Investment Securities of -$83000.0 for Q4 2025, up 3.49% year-over-year from -$80202.2 in Q4 2024, and up 3.49% quarter-over-quarter from -$86000.0 in Q4 2024.

Anteris Technologies Global (AVR) Gains from Investment Securities (2024 - 2025) Analysis & Trends

Anteris Technologies Global (AVR) has 2 years of Gains from Investment Securities data on file, last reported at -$83000.0 in Q4 2025.

  • Gains from Investment Securities for Q4 2025 came in at -$83000.0, up 3.49% year-over-year; the trailing twelve-month figure through Jun 2024 was $475000.0 (changed N/A YoY), and the FY2025 annual result was $52750.0, down 68.59% from the prior year.
  • Gains from Investment Securities rose to -$83000.0 in Q4 2025 per AVR's latest filing, from -$86000.0 in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $475000.0 in Q2 2024 and troughed at -$86000.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn
10 Anteris Technologies Global 779.46 Mn 779.43 Mn 380,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 -83,000.00
Dec 31, 2025 -83,000.00
Dec 31, 2024 -86,000.00
Dec 31, 2024 -86,000.00
Jun 30, 2024 475,000.00
Jun 30, 2024 475,000.00
Mar 31, 2024 4,000.00
Mar 31, 2024 4,000.00